Achieve Market Capitalization from 2010 to 2024
| ACHV Stock | USD 4.38 0.03 0.68% |
Check Achieve Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Achieve Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 271.4 K, Interest Expense of 3 M or Selling General Administrative of 10.9 M, as well as many indicators such as Price To Sales Ratio of 3.23, Dividend Yield of 0.0 or Days Sales Outstanding of 77.88. Achieve financial statements analysis is a perfect complement when working with Achieve Life Valuation or Volatility modules.
Achieve | Market Capitalization |
Latest Achieve Life's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Achieve Life Sciences over the last few years. It is Achieve Life's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Achieve Life's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 150.63 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Achieve Market Capitalization Regression Statistics
| Arithmetic Mean | 33,256,125 | |
| Geometric Mean | 28,540,410 | |
| Coefficient Of Variation | 69.32 | |
| Mean Deviation | 17,448,770 | |
| Median | 22,023,163 | |
| Standard Deviation | 23,052,795 | |
| Sample Variance | 531.4T | |
| Range | 63.7M | |
| R-Value | 0.68 | |
| Mean Square Error | 303.9T | |
| R-Squared | 0.47 | |
| Significance | 0 | |
| Slope | 3,530,316 | |
| Total Sum of Squares | 7440T |
Achieve Market Capitalization History
About Achieve Life Financial Statements
Achieve Life investors use historical fundamental indicators, such as Achieve Life's Market Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Achieve Life. Please read more on our technical analysis and fundamental analysis pages.
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. It has license agreements with Sopharma AD and University of Bristol. Achieve Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Achieve Stock Analysis
When running Achieve Life's price analysis, check to measure Achieve Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Achieve Life is operating at the current time. Most of Achieve Life's value examination focuses on studying past and present price action to predict the probability of Achieve Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Achieve Life's price. Additionally, you may evaluate how the addition of Achieve Life to your portfolios can decrease your overall portfolio volatility.